(Q59649579)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19616828%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

A population-based analysis of the rate of cytoreductive nephrectomy for metastatic renal cell carcinoma in the United States (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19616828%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

metastatic renal cell carcinoma

1 reference

based on heuristic

inferred from title

United States of America

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19616828%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Umberto Capitanio

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19616828%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Giovanni Lughezzani

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19616828%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

12

Pierre I Karakiewicz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19616828%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

7

Maxine Sun

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19616828%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

11

Markus Graefen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19616828%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

9

Paul Perrotte

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19616828%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

10

Francesco Montorsi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19616828%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

6

Shahrokh F Shariat

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19616828%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

4

Hendrik Isbarn

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19616828%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Sara Baillargeon-Gagne

2

object named as

Sara Baillargeon-Gagne

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19616828%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

Daniel Liberman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19616828%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

language of work or name

English

0 references

publication date

18 July 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19616828%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

Urology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19616828%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19616828%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19616828%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

837-841

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19616828%20AND%20SRC:MED&resulttype=core&format=json

Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer

2 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.04.019

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.04.019

Population-based Assessment of Survival After Cytoreductive Nephrectomy Versus No Surgery in Patients With Metastatic Renal Cell Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.04.019

Nephrectomy improves the survival of patients with locally advanced renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.04.019

Thirty-day mortality after nephrectomy: clinical implications for informed consent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.04.019

Cytoreductive nephrectomy in the elderly patient: the M. D. Anderson Cancer Center experience.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.04.019

Patients with renal cell carcinoma nodal metastases can be accurately identified: external validation of a new nomogram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.04.019

Higher incidence of aggressive breast cancers in African-American women: a review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.04.019

Race affects access to nephrectomy but not survival in renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.04.019

Disparities in treatment and outcome for renal cell cancer among older black and white patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.04.019

Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma. Canadian Urologic Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.04.019

Sorafenib in advanced clear-cell renal-cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.04.019

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.04.019

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.04.019

Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.04.019

Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.04.019

Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.04.019

10.1016/J.UROLOGY.2009.04.019

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19616828%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference